Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Bioventus Launches GELSYN-3 to Treat Knee Osteoarthritis Pain - Orthopedic Design & Technology
OEM News

Bioventus Launches GELSYN-3 to Treat Knee Osteoarthritis Pain

Product expands the company's Active Healing Therapies business portfolio.

 Bioventus has launched GELSYN-3, a three-injection hyaluronic acid product for pain relief associated with knee osteoarthritis (OA). A three-injection regimen delivers long-lasting OA knee pain relief for up to six months.1
 
“GELSYN-3 expands the product offering for our US Active Healing Therapies business and gives patients and physicians another choice for effective knee OA pain management,” said Tony Bihl, CEO of Bioventus. “This launch is another milestone at Bioventus and we expect GELSYN-3 to help accelerate our growth in orthobiologics.”
 
OA of the knee involves the breakdown, or degeneration, of cartilage and the synovial fluid that cushions and lubricates joint tissues. Each injection of GELSYN-3 delivers a highly purified solution of hyaluronic acid and is clinically proven effective and safe.
 
Bioventus is a Durham, N.C.-based orthobiologics company that delivers clinically proven, cost-effective products that help people heal. It has two product portfolios for orthobiologics, Bioventus Active Healing Therapies and Bioventus Surgical.

Reference:
1. Pavelka K, Uebelhart D. Efficacy evaluation of highly purified intra-articular hyaluronic acid (Sinovial) vs. hylan G-F20 (Synvisc) in the treatment of symptomatic knee osteoarthritis. A double-blind, controlled, randomized, parallel-group non-inferiority study. Osteoarthritis Cartilage. 2011: 19:1294-1300. This article references Sinovial, the former brand name of GELSYN-3.






























































































































































































































































































































































































































































 
“GELSYN-3 expands the product offering for our US Active Healing Therapies business and gives patients and physicians another choice for effective knee OA pain management,” said Tony Bihl, CEO of Bioventus. “This launch is another milestone at Bioventus and we expect GELSYN-3 to help accelerate our growth as a leader in orthobiologics.”
 
OA of the knee involves the breakdown, or degeneration, of cartilage and the synovial fluid that cushions and lubricates joint tissues. Each injection of GELSYN-3 delivers a highly purified solution of hyaluronic acid and is clinically proven effective and safe.
 
Bioventus is an orthobiologics company that delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. Bioventus has two product portfolios for orthobiologics, Bioventus Active Healing Therapies and Bioventus Surgical, to make it a global leader in active orthopaedic healing.

References:
1. Pavelka K, Uebelhart D. Efficacy evaluation of highly purified intra-articular hyaluronic acid (Sinovial) vs. hylan GF20 (Synvisc®) in the treatment of symptomatic knee osteoarthritis. A double-blind, controlled, randomized,parallel-group non-inferiority study. Osteoarthritis Cartilage. 2011: 19:1294-1300. This article references Sinovial, e former brand name of GELSYN-3.
 

Add us as a preferred source on Google

Get the latest Orthopedic Design & Technology news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Orthopedic Design & Technology Newsletters